Cargando…

Meningococcal carriage in the African meningitis belt

A meningococcal serogroup A polysaccharide/tetanus toxoid conjugate vaccine (PsA-TT) (MenAfriVac#x2122;) is being deployed in countries of the African meningitis belt. Experience with other polysaccharide/protein conjugate vaccines has shown that an important part of their success has been their abi...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2013
Materias:	Meningococcal Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950817/ https://www.ncbi.nlm.nih.gov/pubmed/23682910 http://dx.doi.org/10.1111/tmi.12125

Ejemplares similares

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Meningococcal disease within the Gulf Cooperation Council Countries
por: Al Awaidy, Salah, et al.
Publicado: (2023)

Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination
por: Tan, Litjen (L.J), et al.
Publicado: (2023)

Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam
por: The Nguyen, Phung Nguyen, et al.
Publicado: (2023)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Meningococcal burden of disease in Argentina: 10 years epidemiologic review
por: Neyro, Silvina, et al.
Publicado: (2023)

Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013
por: Lingani, Clément, et al.
Publicado: (2015)

Risk factors for acquisition of meningococcal carriage in the African meningitis belt
por: Cooper, Laura V., et al.
Publicado: (2019)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
por: Robertson, Corwin A., et al.
Publicado: (2023)

Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study
por: Basta, Nicole E., et al.
Publicado: (2018)

Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis
por: Cooper, L. V., et al.
Publicado: (2019)

Preventing invasive meningococcal disease in early infancy
por: Presa, Jessica, et al.
Publicado: (2022)

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine
Publicado: (2015)

Incidence, Carriage and Case-Carrier Ratios for Meningococcal Meningitis in the African Meningitis Belt: A Systematic Review and Meta-Analysis
por: Koutangni, Thibaut, et al.
Publicado: (2015)

Pharyngeal carriage of Neisseria species in the African meningitis belt
por: Diallo, Kanny, et al.
Publicado: (2016)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
por: Marshall, Gary S., et al.
Publicado: (2022)

Real-world impact and effectiveness of MenACWY-TT
por: Villena, Rodolfo, et al.
Publicado: (2023)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Pneumococci in the African Meningitis Belt: Meningitis Incidence and Carriage Prevalence in Children and Adults
por: Mueller, Judith E., et al.
Publicado: (2012)

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico
por: Chacon-Cruz, Enrique, et al.
Publicado: (2022)

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019)

Correction: Pneumococci in the African Meningitis Belt: Meningitis Incidence and Carriage Prevalence in Children and Adults
por: Mueller, Judith E., et al.
Publicado: (2013)

The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis
por: Jaca, Anelisa, et al.
Publicado: (2021)

A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt
por: Manigart, Olivier, et al.
Publicado: (2016)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
por: Dubey, Anand P., et al.
Publicado: (2022)

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014
por: Djingarey, Mamoudou H., et al.
Publicado: (2015)

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study
por: Piazza, Franco M., et al.
Publicado: (2021)

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Weil-Olivier, Catherine, et al.
Publicado: (2022)

Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19
por: Stefanizzi, Pasquale, et al.
Publicado: (2021)

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt
por: Manigart, Olivier, et al.
Publicado: (2016)

Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies
por: Thisyakorn, Usa, et al.
Publicado: (2022)

Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018
por: Bwaka, Ado, et al.
Publicado: (2019)

Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries
por: Dellepiane, Nora, et al.
Publicado: (2015)

Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines
por: Alderson, Mark R, et al.
Publicado: (2019)

Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
por: Karachaliou, Andromachi, et al.
Publicado: (2015)

Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt
por: Diallo, Kanny, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_56ufinfuu4ce11ac610fvi7nis